Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

Market Cap	6.06B +20.5%
Revenue (ttm)	699.33M +33.8%
Net Income	-27.51M
EPS	-0.07
Shares Out	420.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,864,627
Open	14.90
Previous Close	14.98
Day's Range	14.25 - 15.08
52-Week Range	12.75 - 22.55
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688488

Financial Performance

In 2025, SHA:688488's revenue was 719.17 million, an increase of 72.13% compared to the previous year's 417.80 million. Losses were -19.53 million, -86.17% less than in 2024.